Market Entry in the Middle East
09.07.2013 09:28
MENA: Business Strategy & Regulatory Affairs.
This seminar addresses your regulatory affairs options for entering the GCC countries (Kuwait, Saudi Arabia, Bahrain, Qatar, Oman and the UAE), Jordan, Iraq and Egypt.
Termindetails
Wann
24.10.2013 um 10:00 bis
25.10.2013 um 17:00
25.10.2013 um 17:00
Wo
Frankfurt
Kontakttelefon
06221 500 680
Teilnehmer
This seminar will be of benefit to all those working in the pharmaceutical industry who are interested in entering the Middle Eastern market or in keeping their products on the market.
Especially those working in
- general management
- regulatory affairs
- market access/pricing & reimbursement
- business development & sales
will benefit from the seminar.
Please note that this seminar is restricted to 25 participants.
Especially those working in
- general management
- regulatory affairs
- market access/pricing & reimbursement
- business development & sales
will benefit from the seminar.
Please note that this seminar is restricted to 25 participants.
The countries of the Middle East are now going through a period of political change. The current situation holds both risks and opportunities for bringing your pharmaceuticals to the markets.
This seminar addresses your regulatory affairs options for entering the national markets, as well as your pricing and reimbursement options. Which countries offer promising markets for your products and fit your business model? How can you efficiently receive and maintain a marketing authorisation?
After having completed this seminar you will have gained valuable insights into the different health systems and know how to link your business development with your regulatory affairs strategy.
